Review of current nonsurgical management of Peyronie's disease

被引:19
作者
Levine, LA [1 ]
机构
[1] Rush Med Coll, Dept Urol, Chicago, IL 60612 USA
关键词
Peyronie's disease; medical therapy; treatment options;
D O I
10.1038/sj.ijir.3901084
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The current nonsurgical treatment options for men with Peyronie's disease is reviewed. The treatments currently employed and published in the English literature are discussed. A wide variety of nonsurgical treatment options are available to the practicing physician, including oral and topical medications, intralesional injection therapy, as well as employing external energy sources to drive medicine into the tunica albuginea by iontophoresis or direct stimulation of plaque change by shock wave therapy. Nonsurgical treatment of Peyronie's disease clearly has a place in the armamentarium of the practicing urologist. Oral therapy appears to have little therapeutic benefit. Injection and topical approaches deserve further attention. Yet, no single treatment stands out as the most effective remedy for all men with Peyronie's disease. Further controlled, large-scale studies are necessary to establish the benefits of these nonsurgical approaches. In the meantime, combination therapy appears to make sense in the nonsurgical treatment of men with Peyronie's disease.
引用
收藏
页码:S113 / S120
页数:8
相关论文
共 59 条
[11]   ANTIESTROGENS INDUCE THE SECRETION OF ACTIVE TRANSFORMING GROWTH-FACTOR-BETA FROM HUMAN FETAL FIBROBLASTS [J].
COLLETTA, AA ;
WAKEFIELD, LM ;
HOWELL, FV ;
VANROOZENDAAL, KEP ;
DANIELPOUR, D ;
EBBS, SR ;
SPORN, MB ;
BAUM, M .
BRITISH JOURNAL OF CANCER, 1990, 62 (03) :405-409
[12]   INHIBITION OF COLLAGEN SECRETION FROM BONE AND CULTURED FIBROBLASTS BY MICROTUBULAR DISRUPTIVE DRUGS [J].
DIEGELMA.RF ;
PETERKOF.B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1972, 69 (04) :892-&
[13]   REGULATION OF THE PROLIFERATION AND BIOSYNTHETIC ACTIVITIES OF CULTURED HUMAN PEYRONIES DISEASE FIBROBLASTS BY INTERFERONS-ALPHA, INTERFERONS-BETA AND INTERFERONS-GAMMA [J].
DUNCAN, MR ;
BERMAN, B ;
NSEYO, UO .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1991, 25 (02) :89-94
[14]   PERSISTENCE OF A REDUCED-COLLAGEN-PRODUCING PHENOTYPE IN CULTURED SCLERODERMA FIBROBLASTS AFTER SHORT-TERM EXPOSURE TO INTERFERONS [J].
DUNCAN, MR ;
BERMAN, B .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (05) :1318-1324
[15]   MICROTUBULES IN TRANSCELLULAR MOVEMENT OF PROCOLLAGEN [J].
EHRLICH, HP ;
BORNSTEIN, P .
NATURE-NEW BIOLOGY, 1972, 238 (87) :257-+
[16]  
Felipetto R, 1995, Minerva Urol Nefrol, V47, P25
[17]   ULTRASONIC TREATMENT OF PEYRONIES DISEASE [J].
FRANK, IN ;
SCOTT, WW .
JOURNAL OF UROLOGY, 1971, 106 (06) :883-&
[18]   THE NATURAL-HISTORY OF PEYRONIES DISEASE [J].
GELBARD, MK ;
DOREY, F ;
JAMES, K .
JOURNAL OF UROLOGY, 1990, 144 (06) :1376-1379
[19]   THE USE OF COLLAGENASE IN THE TREATMENT OF PEYRONIES DISEASE [J].
GELBARD, MK ;
LINDNER, A ;
KAUFMAN, JJ .
JOURNAL OF UROLOGY, 1985, 134 (02) :280-283
[20]  
GELBARD MK, 1982, UROL RES, V10, P135